reports
- Jakub Krawczyk
- Jakub Krawczyk
- Christian Arnold
- Delphine Brault
- ABGSC Healthcare Research
- Morten Larsen
- Roy Külter
- Steven Boumans
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
SBS STRATEC SE
EL ESSILORLUXOTTICA SA
BRBY BURBERRY GROUP PLC
KER KERING SA
GN GN STORE NORD A/S
01913 PRADA S.P.A.
IMPN IMPLENIA AG
POS PORR AG
SBO SCHOELLER-BLECKMANN OILFIELD EQUIPMENT AG
MONC MONCLER SPA
VGP VGP NV
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
NFN NFON AG
ALFEN ALFEN NV
SPAC 468 SPAC I SE
SUNN SUNRISE
SFZN SIEGFRIED HOLDING AG
- Roy Külter
- Steven Boumans
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
SBS STRATEC SE
EL ESSILORLUXOTTICA SA
BRBY BURBERRY GROUP PLC
KER KERING SA
GN GN STORE NORD A/S
01913 PRADA S.P.A.
IMPN IMPLENIA AG
POS PORR AG
SBO SCHOELLER-BLECKMANN OILFIELD EQUIPMENT AG
MONC MONCLER SPA
VGP VGP NV
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
NFN NFON AG
ALFEN ALFEN NV
SPAC 468 SPAC I SE
SUNN SUNRISE
SFZN SIEGFRIED HOLDING AG
- Oliver Metzger
- ABGSC Healthcare Research
- Morten Larsen
Interim Report Q2 2025: Commercial and operational agility drove marke...
Interim Report Q2 2025: Commercial and operational agility drove market share gains and 46% EBITA growth Highlights The Hearing division delivered 8% organic revenue growth driven by broad-based market share gains of ReSound Vivia across global markets growing below structural trends. The strong growth led to 12% growth in divisional profit, equaling a divisional profit margin of 36% driven by operating leverageThe Enterprise division was – as expected – challenged by market uncertainty due to the global trade environment. The organic revenue growth was -7% due to the market uncertainty an...
- Benoit Valleaux
- René Locher
- Benoit Valleaux
- René Locher
- Christian Arnold
- Delphine Brault
- ABGSC Healthcare Research
- Morten Larsen
Coloplast A/S – Updated presenters list for Capital Markets Day on 2 S...
Coloplast A/S – Updated presenters list for Capital Markets Day on 2 September 2025 Following the changes to the Executive Leadership Team, announced on 19.08.2025*, we are pleased to share with you the updated presenters list for our Capital Markets Day on 2 September 2025. For those of you who have signed up, we look forward to seeing you at the event. The event will take place on Tuesday, 2 September 2025 at Clarion Hotel (Copenhagen airport)Ellehammersvej 20, 2770 Kastrupfrom 10.30 - 17.00 CEST(Central European Summer Time) The event will be held in person at Clarion Hotel in Copenh...
- Maxime Kogge
- Maxime Kogge
- Oliver Metzger
- ABGSC Healthcare Research
- Morten Larsen
- Cor Kluis
Coloplast A/S - Regnskabsmeddelelse, 9M 2024/25
Coloplast A/S - Regnskabsmeddelelse, 9M 2024/25 2024/25 Delårsrapport, 9M 2024/25 1. oktober 2024 - 30. juni 2025 Coloplast leverede en organisk vækst på 7% og en overskudsgrad1 på 28% i 3. kvartal. Den rapporterede omsætning i danske kroner steg 1%, negativt påvirket af valutaudviklingen samt frasalget af hudplejeforretningen. Den organiske vækst pr. forretningsområde: Stomi 6%, Kontinens 8%, Stemme og Respiratorisk Pleje 9%, Avanceret Sårpleje 4% og Urologi 4%.Væksten i Stomi var drevet af et bredt baseret bidrag fra alle regioner, bortset fra Kina, som leverede en lav-encifret v...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.